Loading…

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same k...

Full description

Saved in:
Bibliographic Details
Published in:Journal of computer-aided molecular design 1995-12, Vol.9 (6), p.465-472
Main Authors: Furet, P, Caravatti, G, Lydon, N, Priestle, J P, Sowadski, J M, Trinks, U, Traxler, P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3
cites cdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3
container_end_page 472
container_issue 6
container_start_page 465
container_title Journal of computer-aided molecular design
container_volume 9
creator Furet, P
Caravatti, G
Lydon, N
Priestle, J P
Sowadski, J M
Trinks, U
Traxler, P
description A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.
doi_str_mv 10.1007/BF00124317
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77901518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77901518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</originalsourceid><addsrcrecordid>eNpFkE1LAzEYhIMotVYv3oWcPAir-dpN4k2LrUJFDwrelmSTbaPbbN1kC_33prbo6R14nxmYAeAco2uMEL-5nyCECaOYH4AhzjnNmMzxIRgiSVBW5OzjGJyE8IkSLAs0AAPBhcRCDMH6uTW2aZyfwxB7s4FtDVddG63z8Mt5FSx0fuG0i20XbqF23mzZZXJt0RBV37Vh1XbOW6i8gUnNkzf94sLCYBtbRbd28Td5PH2FOWEYn4KjWjXBnu3vCLxPHt7Gj9nsZfo0vptlFREkZoYqznODdUE0sRUuGKMVQpoWPOecCSbqQmhSW0K14ZpSYUghWW0wkwpLS0fgcpebOn33NsRy6UKVCitv2z6UnEuEcywSeLUDq1QndLYuV51bqm5TYlRuRy7_R07wxT6110tr_tD9qvQHPTt2mQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77901518</pqid></control><display><type>article</type><title>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</title><source>SpringerLink_过刊(NSTL购买)</source><creator>Furet, P ; Caravatti, G ; Lydon, N ; Priestle, J P ; Sowadski, J M ; Trinks, U ; Traxler, P</creator><creatorcontrib>Furet, P ; Caravatti, G ; Lydon, N ; Priestle, J P ; Sowadski, J M ; Trinks, U ; Traxler, P</creatorcontrib><description>A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.</description><identifier>ISSN: 0920-654X</identifier><identifier>EISSN: 1573-4951</identifier><identifier>DOI: 10.1007/BF00124317</identifier><identifier>PMID: 8789188</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Alkaloids - chemistry ; Alkaloids - metabolism ; Alkaloids - pharmacology ; Binding Sites ; Computer Simulation ; Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors ; Cyclic AMP-Dependent Protein Kinases - chemistry ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - metabolism ; Enzyme Inhibitors - pharmacology ; Hydrogen Bonding ; Models, Molecular ; Molecular Conformation ; Molecular Structure ; Phthalimides - chemistry ; Phthalimides - metabolism ; Phthalimides - pharmacology ; Protein Conformation ; Protein Kinase Inhibitors ; Protein Kinases - chemistry ; Receptor, Epidermal Growth Factor - antagonists &amp; inhibitors ; Receptor, Epidermal Growth Factor - chemistry ; Staurosporine ; Thermodynamics</subject><ispartof>Journal of computer-aided molecular design, 1995-12, Vol.9 (6), p.465-472</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</citedby><cites>FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8789188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Furet, P</creatorcontrib><creatorcontrib>Caravatti, G</creatorcontrib><creatorcontrib>Lydon, N</creatorcontrib><creatorcontrib>Priestle, J P</creatorcontrib><creatorcontrib>Sowadski, J M</creatorcontrib><creatorcontrib>Trinks, U</creatorcontrib><creatorcontrib>Traxler, P</creatorcontrib><title>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</title><title>Journal of computer-aided molecular design</title><addtitle>J Comput Aided Mol Des</addtitle><description>A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.</description><subject>Alkaloids - chemistry</subject><subject>Alkaloids - metabolism</subject><subject>Alkaloids - pharmacology</subject><subject>Binding Sites</subject><subject>Computer Simulation</subject><subject>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</subject><subject>Cyclic AMP-Dependent Protein Kinases - chemistry</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Hydrogen Bonding</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Molecular Structure</subject><subject>Phthalimides - chemistry</subject><subject>Phthalimides - metabolism</subject><subject>Phthalimides - pharmacology</subject><subject>Protein Conformation</subject><subject>Protein Kinase Inhibitors</subject><subject>Protein Kinases - chemistry</subject><subject>Receptor, Epidermal Growth Factor - antagonists &amp; inhibitors</subject><subject>Receptor, Epidermal Growth Factor - chemistry</subject><subject>Staurosporine</subject><subject>Thermodynamics</subject><issn>0920-654X</issn><issn>1573-4951</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEYhIMotVYv3oWcPAir-dpN4k2LrUJFDwrelmSTbaPbbN1kC_33prbo6R14nxmYAeAco2uMEL-5nyCECaOYH4AhzjnNmMzxIRgiSVBW5OzjGJyE8IkSLAs0AAPBhcRCDMH6uTW2aZyfwxB7s4FtDVddG63z8Mt5FSx0fuG0i20XbqF23mzZZXJt0RBV37Vh1XbOW6i8gUnNkzf94sLCYBtbRbd28Td5PH2FOWEYn4KjWjXBnu3vCLxPHt7Gj9nsZfo0vptlFREkZoYqznODdUE0sRUuGKMVQpoWPOecCSbqQmhSW0K14ZpSYUghWW0wkwpLS0fgcpebOn33NsRy6UKVCitv2z6UnEuEcywSeLUDq1QndLYuV51bqm5TYlRuRy7_R07wxT6110tr_tD9qvQHPTt2mQ</recordid><startdate>199512</startdate><enddate>199512</enddate><creator>Furet, P</creator><creator>Caravatti, G</creator><creator>Lydon, N</creator><creator>Priestle, J P</creator><creator>Sowadski, J M</creator><creator>Trinks, U</creator><creator>Traxler, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199512</creationdate><title>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</title><author>Furet, P ; Caravatti, G ; Lydon, N ; Priestle, J P ; Sowadski, J M ; Trinks, U ; Traxler, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Alkaloids - chemistry</topic><topic>Alkaloids - metabolism</topic><topic>Alkaloids - pharmacology</topic><topic>Binding Sites</topic><topic>Computer Simulation</topic><topic>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</topic><topic>Cyclic AMP-Dependent Protein Kinases - chemistry</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Hydrogen Bonding</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Molecular Structure</topic><topic>Phthalimides - chemistry</topic><topic>Phthalimides - metabolism</topic><topic>Phthalimides - pharmacology</topic><topic>Protein Conformation</topic><topic>Protein Kinase Inhibitors</topic><topic>Protein Kinases - chemistry</topic><topic>Receptor, Epidermal Growth Factor - antagonists &amp; inhibitors</topic><topic>Receptor, Epidermal Growth Factor - chemistry</topic><topic>Staurosporine</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Furet, P</creatorcontrib><creatorcontrib>Caravatti, G</creatorcontrib><creatorcontrib>Lydon, N</creatorcontrib><creatorcontrib>Priestle, J P</creatorcontrib><creatorcontrib>Sowadski, J M</creatorcontrib><creatorcontrib>Trinks, U</creatorcontrib><creatorcontrib>Traxler, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of computer-aided molecular design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furet, P</au><au>Caravatti, G</au><au>Lydon, N</au><au>Priestle, J P</au><au>Sowadski, J M</au><au>Trinks, U</au><au>Traxler, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</atitle><jtitle>Journal of computer-aided molecular design</jtitle><addtitle>J Comput Aided Mol Des</addtitle><date>1995-12</date><risdate>1995</risdate><volume>9</volume><issue>6</issue><spage>465</spage><epage>472</epage><pages>465-472</pages><issn>0920-654X</issn><eissn>1573-4951</eissn><abstract>A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.</abstract><cop>Netherlands</cop><pmid>8789188</pmid><doi>10.1007/BF00124317</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-654X
ispartof Journal of computer-aided molecular design, 1995-12, Vol.9 (6), p.465-472
issn 0920-654X
1573-4951
language eng
recordid cdi_proquest_miscellaneous_77901518
source SpringerLink_过刊(NSTL购买)
subjects Alkaloids - chemistry
Alkaloids - metabolism
Alkaloids - pharmacology
Binding Sites
Computer Simulation
Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors
Cyclic AMP-Dependent Protein Kinases - chemistry
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - metabolism
Enzyme Inhibitors - pharmacology
Hydrogen Bonding
Models, Molecular
Molecular Conformation
Molecular Structure
Phthalimides - chemistry
Phthalimides - metabolism
Phthalimides - pharmacology
Protein Conformation
Protein Kinase Inhibitors
Protein Kinases - chemistry
Receptor, Epidermal Growth Factor - antagonists & inhibitors
Receptor, Epidermal Growth Factor - chemistry
Staurosporine
Thermodynamics
title Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A15%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modelling%20study%20of%20protein%20kinase%20inhibitors:%20binding%20mode%20of%20staurosporine%20and%20origin%20of%20the%20selectivity%20of%20CGP%2052411&rft.jtitle=Journal%20of%20computer-aided%20molecular%20design&rft.au=Furet,%20P&rft.date=1995-12&rft.volume=9&rft.issue=6&rft.spage=465&rft.epage=472&rft.pages=465-472&rft.issn=0920-654X&rft.eissn=1573-4951&rft_id=info:doi/10.1007/BF00124317&rft_dat=%3Cproquest_cross%3E77901518%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77901518&rft_id=info:pmid/8789188&rfr_iscdi=true